The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 17, 2024
Filed:
Apr. 19, 2022
Applicant:
Glycocore Pharma Srl, Como, IT;
Inventors:
Lanfranco Callegaro, Como, IT;
Giulio Bianchini, Como, IT;
Assignee:
GLYCOCORE PHARMA, Como, IT;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/722 (2006.01); A61K 31/136 (2006.01); A61K 31/137 (2006.01); A61K 31/4178 (2006.01); A61K 31/46 (2006.01); A61K 31/4745 (2006.01); A61K 31/522 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/722 (2013.01); A61K 31/136 (2013.01); A61K 31/137 (2013.01); A61K 31/4178 (2013.01); A61K 31/46 (2013.01); A61K 31/4745 (2013.01); A61K 31/522 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 31/14 (2018.01);
Abstract
The invention discloses a functionalised chitosan, or a salt thereof, used in the treatment of pathologies of the respiratory tract or hepatic pathologies, preferably caused by viral infections. It was indeed observed that said functionalised chitosan or salt thereof was able to act as galectin-modulator, modulating in particular galectin-3, and therefore determining a marked reduction in the inflammatory and fibrotic cascade generated by these viral infections. The invention moreover discloses a pharmaceutical composition, as well as a biomaterial, comprising this functionalised chitosan, or a salt thereof.